IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

VG Life Sciences Inc

CUSIP: 91822T101 | 3 institutional holders

Quarters

Q1 2026Q3 2023Q2 2023Q4 2022Q2 2017
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2026

Hanson & Doremus Investment Management67
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Hanson & Doremus Investment Management
67$00.0%CoreVery LowBurlington, VT2026-04-17